Bpc 157 Acetate Powder NDC73212 002 FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of They Call It the 'Wolverine Peptide.' And Everyone from Biohackers to Your Dad Wants It Now. Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding.